The Ability of Vaped Marijuana to Reduce the Severity ofNaloxone-Precipitated Withdrawal
Does Marijuana Reduce Opioid Withdrawal?
Sponsor: National Institute on Drug Abuse
Enrolling: Male and Female Patients
Study Length: 28 Days
IRB Number: 8061
U.S. Govt. ID: NCT05114460
Contact: Jermaine Jones: 646-774-6113 / jermaine.jones@nyspi.columbia.edu
Additional Study Information: Naloxone-induced withdrawal is also common in out-of-hospital settings in which non-medical persons are asked to administer naloxone to save the lives of their peers. Concerns about the adverse effects of naloxone administration may prevent or delay the use of this lifesaving intervention. The goal of the proposed, proof-of-concept study is to test the combined effects of vaporized marijuana Delta-9-tetrahydracannabinol (THC) with naloxone as a proof of concept towards the possible development of a combined overdose reversal agent with improved tolerability.
This study is closed
Investigator
Jermaine Jones, PhD
Do You Qualify?
Are you between the ages of 18-55? Yes No
Do you use opioids like heroin or fentanyl? Yes No
Are in in treatment for opioid use disorders (e.g., methadone or buprenorphine)? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Jermaine Jones
jermaine.jones@nyspi.columbia.edu
646-774-6113